Cargando…

Oroxylin A inhibits colitis by inactivating NLRP3 inflammasome

NLRP3 inflammasome is a novel therapeutic target for inflammatory bowel disease (IBD). The aim of this study was to investigate the anti-inflammatory effect of a bioactive flavonoid—oroxylin A on the treatment of dextran sulfate sodium (DSS)-induced murine colitis via targeting NLRP3 inflammasome. I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Wei, Liu, Xiuting, Zhang, Xin, Tang, Jingjing, Li, Zhiyu, Wang, Qing, Hu, Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601702/ https://www.ncbi.nlm.nih.gov/pubmed/28938606 http://dx.doi.org/10.18632/oncotarget.19440

Ejemplares similares

GPA peptide inhibits NLRP3 inflammasome activation to ameliorate colitis through AMPK pathway
por: Deng, Zhao, et al.
Publicado: (2020)

Lonicerin targets EZH2 to alleviate ulcerative colitis by autophagy-mediated NLRP3 inflammasome inactivation
por: Lv, Qi, et al.
Publicado: (2021)

Oroxylin A inhibits the generation of Tregs in non-small cell lung cancer
por: Shen, Le, et al.
Publicado: (2017)

Inhibiting the NLRP3 Inflammasome
por: El-Sharkawy, Lina Y., et al.
Publicado: (2020)

Contradictory Effects of NLRP3 Inflammasome Regulatory Mechanisms in Colitis
por: Wagatsuma, Kohei, et al.
Publicado: (2020)

Munronoid I Ameliorates DSS-Induced Mouse Colitis by Inhibiting NLRP3 Inflammasome Activation and Pyroptosis Via Modulation of NLRP3
por: Ma, Xingyu, et al.
Publicado: (2022)

Gallic acid ameliorates dextran sulfate sodium-induced ulcerative colitis in mice via inhibiting NLRP3 inflammasome
por: Yu, Tian-Yuan, et al.
Publicado: (2023)

PSMB5 Alleviates Ulcerative Colitis by Inhibiting ROS-Dependent NLRP3 Inflammasome-Mediated Pyroptosis
por: Han, Liang, et al.
Publicado: (2022)

Huaier aqueous extract protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting NLRP3 inflammasome activation
por: Wang, Lijuan, et al.
Publicado: (2017)

Caffeic Acid Phenethyl Ester Prevents Colitis-Associated Cancer by Inhibiting NLRP3 Inflammasome
por: Dai, Guoliang, et al.
Publicado: (2020)

Celastrol ameliorates inflammation through inhibition of NLRP3 inflammasome activation
por: Yu, Xianjun, et al.
Publicado: (2017)

Activation of Cannabinoid Receptor 2 Ameliorates DSS-Induced Colitis through Inhibiting NLRP3 Inflammasome in Macrophages
por: Ke, Ping, et al.
Publicado: (2016)

Evodiamine Attenuates Experimental Colitis Injury Via Activating Autophagy and Inhibiting NLRP3 Inflammasome Assembly
por: Ding, Wenwen, et al.
Publicado: (2020)

Ononin alleviates DSS‐induced colitis through inhibiting NLRP3 inflammasome via triggering mitophagy
por: Yu, Ting, et al.
Publicado: (2023)

Formononetin Administration Ameliorates Dextran Sulfate Sodium-Induced Acute Colitis by Inhibiting NLRP3 Inflammasome Signaling Pathway
por: Wu, Dacheng, et al.
Publicado: (2018)

Deoxycholic Acid Triggers NLRP3 Inflammasome Activation and Aggravates DSS-Induced Colitis in Mice
por: Zhao, Shengnan, et al.
Publicado: (2016)

Therapeutic interventions target the NLRP3 inflammasome in ulcerative colitis: Comprehensive study
por: Ali, Fares E.M, et al.
Publicado: (2023)

Oroxylin A modulates mitochondrial function and apoptosis in human colon cancer cells by inducing mitochondrial translocation of wild-type p53
por: Qiao, Chen, et al.
Publicado: (2016)

Inhibition of the PERK/TXNIP/NLRP3 Axis by Baicalin Reduces NLRP3 Inflammasome-Mediated Pyroptosis in Macrophages Infected with Mycobacterium tuberculosis
por: Fu, Yan, et al.
Publicado: (2021)

Tanshinone IIA attenuates atherosclerosis via inhibiting NLRP3 inflammasome activation
por: Wen, Jiexia, et al.
Publicado: (2020)

NLRP3 Inflammasome as a Molecular Marker in Diabetic Cardiomyopathy
por: Luo, Beibei, et al.
Publicado: (2017)

Ketogenic diet ameliorates inflammation by inhibiting the NLRP3 inflammasome in osteoarthritis
por: Kong, Ganggang, et al.
Publicado: (2022)

Retracted: PSMB5 Alleviates Ulcerative Colitis by Inhibiting ROS-Dependent NLRP3 Inflammasome-Mediated Pyroptosis
por: Markers, Disease
Publicado: (2023)

Fluoxetine Inhibits NLRP3 Inflammasome Activation: Implication in Depression
por: Du, Ren-Hong, et al.
Publicado: (2016)

NLRP3 inflammasome activation in response to metals
por: Huang, Wanyi, et al.
Publicado: (2023)

Corrigendum to “Formononetin Administration Ameliorates Dextran Sulfate Sodium-Induced Acute Colitis by Inhibiting NLRP3 Inflammasome Signaling Pathway”
por: Wu, Dacheng, et al.
Publicado: (2018)

MALT1 inhibitors prevent the development of DSS-induced experimental colitis in mice via inhibiting NF-κB and NLRP3 inflammasome activation
por: Liu, Wen, et al.
Publicado: (2016)

A novel mechanism for NLRP3 inflammasome activation
por: Zhang, Tan, et al.
Publicado: (2022)

Mangiferin from Pueraria tuberosa reduces inflammation via inactivation of NLRP3 inflammasome
por: Bulugonda, Ramakrishna K., et al.
Publicado: (2017)

Inhibition of the NLRP3 inflammasome prevents ovarian aging
por: Navarro-Pando, José M., et al.
Publicado: (2021)

Inhibition of the NLRP3 inflammasome by HSP90 inhibitors
por: Nizami, Sohaib, et al.
Publicado: (2020)

Activation and Inhibition of the NLRP3 Inflammasome by RNA Viruses
por: Choudhury, SK Mohiuddin, et al.
Publicado: (2021)

NLRP3 inflammasome-mediated pyroptosis contributes to the pathogenesis of non-ischemic dilated cardiomyopathy
por: Zeng, Cheng, et al.
Publicado: (2020)

Titanium dioxide nanoparticles exacerbate DSS-induced colitis: role of the NLRP3 inflammasome
por: Ruiz, Pedro A, et al.
Publicado: (2017)

Ruscogenin Ameliorated Sjögren's Syndrome by Inhibiting NLRP3 Inflammasome Activation
por: He, Jing, et al.
Publicado: (2022)

Berberine protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition involving the inactivation of the NLRP3 inflammasome
por: Ma, Zejun, et al.
Publicado: (2022)

Protection by simvastatin on hyperglycemia-induced endothelial dysfunction through inhibiting NLRP3 inflammasomes
por: Lv, Zhen-Huan, et al.
Publicado: (2017)

Inhibition of the Inflammasome Activity of NLRP3 Attenuates HDM-Induced Allergic Asthma
por: Ma, Ming, et al.
Publicado: (2021)

MyD88 in macrophages protects against colitis via inhibiting the activation of NLRP3 inflammasome in epithelial cells
por: Liu, Shi, et al.
Publicado: (2022)

3,4-Methylenedioxy-β-Nitrostyrene Alleviates Dextran Sulfate Sodium–Induced Mouse Colitis by Inhibiting the NLRP3 Inflammasome
por: Zheng, Juanjuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4vd7rff9mi3i06s4cdfd6emkq5